Cibus Inc 2025年季度报告

FORM10-Q (Exact name of registrant as specified in its charter) 27-1967997(I.R.S. EmployerIdentification No.) 92121(Zip Code) (858)450-0008(Registrant’s telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller Table of Contents PART I. FINANCIAL INFORMATIONItem 1. Condensed Consolidated Financial StatementsItem 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsItem 4. Controls and ProceduresPART II. OTHER INFORMATIONItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales of Equity Securities and Use of ProceedsItem 5. Other InformationItem 6. ExhibitsSIGNATURES Terms When the terms “Cibus,” the “Company” or “its” are used in this report, unless the context otherwise requires, those terms are being used to refer toCibus, Inc. and its consolidated subsidiaries. When the term “Cibus Global” is used, it is being used to refer to Cibus Global, LLC. The Company owns or has the right to use the trademarks, service marks, and trade names that it uses in conjunction with the operation of itsbusiness.Some of the more important marks and names that it owns or has rights to use that may appear in this Quarterly Report on Form 10-Qinclude: “Cibus,” “RTDS,” “Rapid Trait Development System,” “Trait Machine,” and “Future of Breeding.” This report may also containTMTMTM ®® additional trade names, trademarks, and service marks belonging to other companies. The Company does not intend its use or display of other parties’ trademarks, trade names, or service marks to imply, and such use or display should not be construed to imply a relationship with, or endorsement orsponsorship of these other parties.Cautionary Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27Aof the Securities Act of 1933, as amended (the Securities Act) and the rules and regulations promulgated thereunder, and Section 21E of the SecuritiesExchange Act of 1934, as amended (the Exchange Act) and the rules and regulations promulgated thereunder. The Company may also make forward- The Company has made these forward-looking statements in reliance on the safe harbor provisions of the United States Private Securities LitigationReform Act of 1995. Although the company believes the expectations reflected in the forward-looking statements are reasonable, it cannot guaranteefuture results, level of activity, performance or achievements. In some cases, you can identify these statements by forward-looking words such as“anticipates,” “believes,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “predicts,” “projects,” “scheduled,”“should,” “targets,” “will,” “would,” or the negative of these terms and other similar terminology. Forward-looking statements in this report includestatements about the Company’s future financial performance, including its liquidity and capital resources, cash runway, and its ability to continue asa going concern; the advancement, timing and progress of the Company’s platform development and trait development in crop platforms; theanticipated timing for the presentation of data related to trait development and other operational activities; the timeframes for transferring traits incustomers’ elite germplasm; the timeframe for commercialization of germplasm with the Company’s traits by seed company customers; the timingfor, and degree of, adoption by farmers of germplasm with the Company’s traits following commercialization; the capacity of the Company’sproductivity traits to deliver competitive yield improvements; the ability of gene editing to address climate change at scale; the timing and nature of challenges associated with the Company’s ability to effectively license its productivity traits and sustainable ingredient products; the risk that farmersdo not recognize the value in germplasm containing the Company’s traits or that farmers and processors fail to work effectively with crops containingthe Company’s traits; delays or disruptions in the Company’s platform or trait product development efforts, particularly with respect to its non-Riceand non